title: Will chemotherapy change the management of prostate cancer?
authors.affiliation: Medical Research Council Clinical Trials Unit, Guy's Hospital, London, UK.|Department of Medical Oncology, Guy's Hospital, London, UK.
authors.forename: Clare
authors.initials: C
authors.lastname: Gilson
authors.affiliation: Medical Research Council Clinical Trials Unit, Guy's Hospital, London, UK.
authors.forename: Matthew R
authors.identifier: 0000-0002-9323-1371
authors.initials: MR
authors.lastname: Sydes
authors.affiliation: Department of Medical Oncology, Guy's Hospital, London, UK.
authors.forename: Simon
authors.initials: S
authors.lastname: Chowdhury
mesh_terms: D000726:Androgen Antagonists / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D000077143:Docetaxel; D006801:Humans; D008297:Male; D009362:Neoplasm Metastasis / Q000188:drug therapy; D011471:Prostatic Neoplasms / Q000188:drug therapy* / Q000473:pathology; D018570:Risk Assessment; D043823:Taxoids / Q000627:therapeutic use*; D016896:Treatment Outcome
chemical_list: D000726:Androgen Antagonists; D000970:Antineoplastic Agents; D043823:Taxoids; D000077143:Docetaxel